Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00201214 · ClinicalTrials.gov registry record · Phase 1

Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery

A Phase 1 study, sponsored by Vanderbilt University.

Completed
Registry status
Phase 1
Development phase
26
Enrollment target

NCT00201214: Completed Phase 1 study, sponsored by Vanderbilt University.

NCT00201214 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00201214, a Phase 1 study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 1
Development phase
26 participants
Enrollment target

Study Summary

This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.

Interventions

  • DRUG Citrulline

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2003-12
Est. Completion 2009-12
Phase Phase 1
Vanderbilt University

430 total trials

What the finished NCT00201214 record still lists

NCT00201214 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 1 intervention - of which Citrulline is the first listed.

NCT00201214 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00201214 about?

NCT00201214 is a clinical study titled "Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery". This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.

What is the current status of trial NCT00201214?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2003-12. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00201214?

The interventions under investigation include: Citrulline (DRUG).

Who is sponsoring clinical trial NCT00201214?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00201214's enrollment target sits among peer trials

26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00201214, the US trial registry maintained by the National Library of Medicine. NCT00201214 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.